Imaging analytics software start-up HealthMyne said it has received $4.5 million in a Series A investment round.
Founded in 2013 by healthcare industry executives with experience at firms such as TomoTherapy, Geometrics, and UltraVisual, HealthMyne is developing search, analytics, and imaging software targeted at cancer providers, according to the company. It will offer tumor image manipulation tools, along with capabilities to search electronic health records and image repositories for diagnosing and treating similar cases, HealthMyne said.
Slated for introduction later this year, HealthMyne's first product is designed to aid clinicians in detecting and diagnosing lung nodules in low-dose CT lung cancer screening programs, according to the firm.
The venture capital financing was led by Venture Investors and 4490 Ventures, with additional participation from HealthX Ventures and several prominent angel investors, HealthMyne said. The company will use the funds to support its product development, regulatory, and commercialization efforts.
